[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. https://doi.org/10.3322/caac.21708
|
[2]
|
Liu, J., Dong, L., Zhu, Y., et al. (2022) Prostate Cancer Treat-ment—China’s Perspective. Cancer Letters, 550, Article ID: 215927. https://doi.org/10.1016/j.canlet.2022.215927
|
[3]
|
雷海科, 宋彦平, 李小升, 等. 前列腺癌患者生存随访调查及预后影响因素研究[J]. 中国男科学杂志, 2020, 34(2): 8-14.
|
[4]
|
Rao, K., Liang, S., Cardamone, M., et al. (2018) Cost Implications of PSA Screening Differ by Age. Bmc Urology, 18, Article No. 38. https://doi.org/10.1186/s12894-018-0344-5
|
[5]
|
雷银, 吴汶钊, 李天杰, 等. 前列腺穿刺与前列腺癌根治术后Gleason评分的比较[J]. 现代泌尿生殖肿瘤杂志, 2020, 12(6): 338-342.
|
[6]
|
Kurhanewicz, J., Jung, A.J. and Vigneron, D.B. (2013) Role of Imaging as an Adjunct or Replacement for Biopsy: American Experience. In: Jones, J. Ed., Prostate Cancer Diagnosis. Current Clinical Urology. Humana Press, Totowa.
https://doi.org/10.1007/978-1-62703-188-2_23
|
[7]
|
任秀娟, 红华, 周亮强, 等. 超声影像组学联合临床指标预测前列腺癌[J]. 中国超声医学杂志, 2022, 38(2): 196-200.
|
[8]
|
Lone, S.N., Nisar, S., Masoodi, T., et al. (2022) Liquid Biopsy: A Step Closer to Transform Diagnosis, Prognosis and Future of Cancer Treatments. Molecular Cancer, 21, Article No. 79. https://doi.org/10.1186/s12943-022-01543-7
|
[9]
|
Li, W., Liu, J.B., Hou, L.K., et al. (2022) Liquid Biopsy in Lung Cancer: Significance in Diagnostics, Prediction, and Treatment Monitoring. Molecular Cancer, 21, 25.
|
[10]
|
Yu, W., Hurley, J., Roberts, D., et al. (2021) Exosome-Based Liquid Biopsies in Cancer: Opportunities and Challenges. Annals of Oncology, 32, 466-477. https://doi.org/10.1016/j.annonc.2021.01.074
|
[11]
|
Coradduzza, D., Cruciani, S., Arru, C., et al. (2022) Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer. International Journal of Molecular Sciences, 23, Article 1626. https://doi.org/10.3390/ijms23031626
|
[12]
|
Menon, A., Abd-Aziz, N., Khalid, K., Poh, C.L., Naidu, R. (2022) miRNA: A Promising Therapeutic Target in Cancer. International Journal of Molecular Sciences, 23, Article 11502. https://doi.org/10.3390/ijms231911502
|
[13]
|
Volinia, S., Calin, G.A., Liu, C.G., et al. (2006) A microRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets. Proceed-ings of the National Academy of Sciences of the United States of America, 103, 2257-2261. https://doi.org/10.1073/pnas.0510565103
|
[14]
|
Groen, L. and Schalken, J. (2022) Liquid Biopsy for Prostate and Bladder Cancer: Progress and Pitfalls. European Urology Focus, 8, 904-906. https://doi.org/10.1016/j.euf.2022.08.013
|
[15]
|
Crocetto, F., Russo, G., Di Zazzo, E., et al. (2022) Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives. Cancers, 14, Article 3272. https://doi.org/10.3390/cancers14133272
|
[16]
|
Chen, X., Ba, Y., Ma, L., et al. (2008) Characterization of mi-croRNAs in Serum: A Novel Class of Biomarkers for Diagnosis of Cancer and Other Diseases. Cell Research, 18, 997-1006. https://doi.org/10.1038/cr.2008.282
|
[17]
|
Lan, H., Lu, H., Wang, X. and Jin, H. (2015) MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges. BioMed Research International, 2015, Article ID: 125094. https://doi.org/10.1155/2015/125094
|
[18]
|
Fabris, L., Ceder, Y., Chinnaiyan, A.M., et al. (2016) The Potential of MicroRNAs as Prostate Cancer Biomarkers. European Urology, 70, 312-322. https://doi.org/10.1016/j.eururo.2015.12.054
|
[19]
|
Ambs, S., Prueitt, R.L., Yi, M., et al. (2008) Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer. Cancer Research, 68, 6162-6170.
https://doi.org/10.1158/0008-5472.CAN-08-0144
|
[20]
|
Porkka, K.P., Pfeiffer, M.J., Waltering, K.K. , et al. (2007) Research Article MicroRNA Expression Profiling in Prostate Cancer. Cancer Research, 67, 6130-6135. https://doi.org/10.1158/0008-5472.CAN-07-0533
|
[21]
|
黄俊, 王清华, 郭佳. 前列腺癌诊断和预后相关生物标志物的研究进展[J]. 现代泌尿生殖肿瘤杂志, 2021, 13(6): 375-378.
|
[22]
|
Moltzahn, F., Olshen, A.B., Baehner, L., et al. (2011) Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients. Cancer Research, 71, 550-560.
https://doi.org/10.1158/0008-5472.CAN-10-1229
|
[23]
|
Bryant, R.J., Pawlowski, T., Catto, J., et al. (2012) Changes in Circulating microRNA Levels Associated with Prostate Cancer. British Journal of Cancer, 106, 768-74. https://doi.org/10.1038/bjc.2011.595
|
[24]
|
Li, Z., Ma, Y.Y., Wang, J., et al. (2015) Exosomal microRNA-141 Is Upregulated in the Serum of Prostate Cancer Patients. OncoTargets and Therapy, 9, 139-148. https://doi.org/10.2147/OTT.S95565
|
[25]
|
Endzeliņš, E., Berger, A., Melne, V., et al. (2017) Detection of Circulat-ing miRNAs: Comparative Analysis of Extracellular Vesicle-Incorporated miRNAs and Cell-Free miRNAs in Whole Plasma of Prostate Cancer Patients. BMC Cancer, 17, Article No. 730. https://doi.org/10.1186/s12885-017-3737-z
|
[26]
|
Chen, Z.H., Zhang, G.L., Li, H.R., et al. (2012) A Panel of Five Circulating microRNAs as Potential Biomarkers for Prostate Cancer. Prostate, 72, 1443-1452. https://doi.org/10.1002/pros.22495
|
[27]
|
史浩天, 范学武, 田龙, 胡逸民. miRNA-182与miRNA-187联合检测对前列腺癌诊断的价值[J]. 国际检验医学杂志, 2022, 43(6): 759-762.
|
[28]
|
任超. 尿液中miRNA-24-3p联合miRNA-222-3p检测在前列腺癌中的诊断及临床意义[J]. 天津医科大学学报, 2022, 28(2): 181-185.
|
[29]
|
Llorente, A., Skotland, T., Sylv?Nne, T., et al. (2013) Molecular Lipidomics of Exosomes Released by PC-3 Prostate Cancer Cells. Biochimica et Biophysica Acta (BBA) —Molecular and Cell Biology of Lipids, 1831, 1302-1309.
https://doi.org/10.1016/j.bbalip.2013.04.011
|
[30]
|
Rodríguez, M., Bajo-Santos, C., Hessvik, N.P., et al. (2017) Identification of Non-Invasive miRNAs Biomarkers for Prostate Cancer by Deep Sequencing Analysis of Urinary Exo-somes. Molecular Cancer, 16, Article No. 156.
https://doi.org/10.1186/s12943-017-0726-4
|
[31]
|
Pellegrini, K.L., Patil, D., Douglas, K.J.S., et al. (2017) Detection of Prostate Cancer-Specific Transcripts in Extracellular Vesicles Isolated from Post-DRE Urine. Prostate, 77, 990-999. https://doi.org/10.1002/pros.23355
|
[32]
|
McKiernan, J., Donovan, M.J., O’Neill, V., et al. (2016) A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncology, 2, 882-889.
https://doi.org/10.1001/jamaoncol.2016.0097
|
[33]
|
张国颖, 李俊, 白宇, 等. miR-183通过抑制CAND1促进前列腺癌病理进程[J]. 中国老年学杂志, 2022, 42(3): 698-701.
|
[34]
|
Konoshenko, M.Y., Bryzgunova, O.E. and Lak-tionov, P.P. (2021) miRNAs and Androgen Deprivation Therapy for Prostate Cancer. Biochimica et Biophysica Acta (BBA) —Reviews on Cancer, 1876, Article ID: 188625.
https://doi.org/10.1016/j.bbcan.2021.188625
|
[35]
|
张泉波, 李玉莲, 陈绮, 张艳艳, 陈国荣. 基于TCGA数据库构建前列腺癌相关miRNA预后模型[J]. 浙江医学, 2021, 43(18): 1971-1978+2049-2050.
|
[36]
|
Huang, X., Yuan, T., Liang, M., et al. (2015) Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-Resistant Prostate Cancer. European Urology, 67, 33-41. https://doi.org/10.1016/j.eururo.2014.07.035
|
[37]
|
Wani, S., Kaul, D., Mavuduru, R.S., Kakkar, N. and Bhatia, A. (2017) Urinary-Exosomal miR-2909: A Novel Pathognomonic Trait of Prostate Cancer Severity. Journal of Biotechnology, 259, 135-139.
https://doi.org/10.1016/j.jbiotec.2017.07.029
|
[38]
|
Foj, L., Ferrer, F., Serra, M., et al. (2017) Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis. Prostate, 77, 573-583. https://doi.org/10.1002/pros.23295
|
[39]
|
Albino, D., Falcione, M., Uboldi, V., et al. (2021) Circulating Extracellular Vesicles Release Oncogenic miR-424 in Experimental Models and Patients with Aggressive Prostate Cancer. Communi-cations Biology, 4, Article No. 119.
https://doi.org/10.1038/s42003-020-01642-5
|
[40]
|
Larne, O., Martens-Uzunova, E., Hagman, Z., et al. (2013) miQ—A Novel microRNA Based Diagnostic and Prognostic Tool for Prostate Cancer. International Journal of Cancer, 132, 2867-2875. https://doi.org/10.1002/ijc.27973
|
[41]
|
Hasegawa, T., Glavich, G.J., Pahuski, M., et al. (2018) Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate. Molecular Cancer Re-search, 16, 669-681.
https://doi.org/10.1158/1541-7786.MCR-17-0321
|
[42]
|
Dai, Y. and Gao, X. (2021) Inhibition of Cancer Cell-Derived Exosomal microRNA-183 Suppresses Cell Growth and Metastasis in Prostate Cancer by Upregulating TPM1. Cancer Cell International, 21, Article No. 145.
https://doi.org/10.1186/s12935-020-01686-x
|
[43]
|
辛以军, 徐蓬永, 栾建波. miR-92a靶向调控STARD13表达促进前列腺癌DU145细胞侵袭和迁移的实验研究[J]. 河北医药, 2021, 43(15): 2260-2264.
|
[44]
|
刘绍祖, 黄晓华. 前列腺癌组织中miR-449a、miR-493-5p表达与临床病理参数及预后的关系[J]. 中国性科学, 2021, 30(7): 33-36.
|
[45]
|
Jiang, S., Mo, C., Guo, S., et al. (2019) Human Bone Marrow Mesenchymal Stem Cells-Derived mi-croRNA-205- Containing Exosomes Impede the Progression of Prostate Cancer through Suppression of RHPN2. Jour-nal of Experimental & Clinical Cancer Research, 38, Article No. 495. https://doi.org/10.1186/s13046-019-1488-1
|
[46]
|
李正平, 翟高杰. miR-299-5p在前列腺癌中的表达及对细胞生物行为学的影响[J]. 中国免疫学杂志, 2021, 37(9): 1088-1093.
|
[47]
|
Guo, C., Liu, J., Zhou, Q., et al. (2020) Exo-somal Noncoding RNAs and Tumor Drug Resistance. Cancer Research, 80, 4307-4313. https://doi.org/10.1158/0008-5472.CAN-20-0032
|
[48]
|
Zhang, Y., Zhao, J., Ding, M., et al. (2020) Loss of Exo-somal miR-146a-5p from Cancer-Associated Fibroblasts after Androgen Deprivation Therapy Contributes to Prostate Cancer Metastasis. Journal of Experimental & Clinical Cancer Research, 39, Article No. 282. https://doi.org/10.1186/s13046-020-01761-1
|
[49]
|
Li, J., Yang, X., Guan, H., et al. (2016) Exosome-Derived mi-croRNAs Contribute to Prostate Cancer Chemoresistance. International Journal of Oncology, 49, 838-846. https://doi.org/10.3892/ijo.2016.3560
|
[50]
|
Corcoran, C., Rani, S. and O’Driscoll, L. (2014) miR-34a Is an Intra-cellular and Exosomal Predictive Biomarker for Response to Docetaxel with Clinical Relevance to Prostate Cancer Pro-gression. Prostate, 74, 1320-1334.
https://doi.org/10.1002/pros.22848
|
[51]
|
Hoey, C., Ray, J., Jeon, J., et al. (2018) miRNA-106a and Prostate Cancer Radioresistance: A Novel Role for LITAF in ATM Regulation. Molecular Oncology, 12, 1324-1341. https://doi.org/10.1002/1878-0261.12328
|
[52]
|
Duan, X.M., Liu, X.N., Li, Y.X., et al. (2019) MicroRNA-498 Promotes Proliferation, Migration, and Invasion of Prostate Cancer Cells and Decreases Radiation Sensitivity by Target-ing PTEN. The Kaohsiung Journal of Medical Sciences, 35, 659-671. https://doi.org/10.1002/kjm2.12108
|
[53]
|
董青川, 张治国, 程继, 等. miR-155对前列腺癌放射治疗的增敏作用[J]. 武警医学, 2017, 28(1): 60-63, 67.
|